期刊文献+

CEA,CA19—9,CA72—4标志物在结直肠癌监测中的应用价值 被引量:2

Application of monitoring partial serum tumor maker in colorectal cancer
下载PDF
导出
摘要 目的:探讨CEA,CA19—9,CA72—4三项肿瘤标志物单项或联合监测对结直肠癌临床诊断及复发中的应用价值。方法:采用化学发光法对结直肠癌组72例(包括复发组40例和无复发组32例),健康对照组35例的血清CEA.CA19—9.CA72—4三项肿瘤标志物进行检测及统计学分析。结果:CEA,CA19—9,CA72—4在结直肠癌组显著高于健康对照组(均P〈0.01);在复发组与无复发组3种肿瘤标志物含量明显增高,总体水平差异均有统计学意义(P〈0.01),单项检测中:CA19—9,CA72—4的阳性率无差异,但冠著高于CEA;CEA+724+CA19—9联合检测的阳性率显著高于单项和CEA+CA19—9。CEA+CA724及CA19—9+CA72—4的联合。结论:CEA,CA19-9,CA72—4肿瘤标志物联合检测可以提高结直肠癌诊断的敏感度并对结直肠癌复发监测具有较高的临床应用价值。 Objective:To evaluate the application of single or combined detection three tumor markers CEA,CA 19-9,CA72-4 in clinical diagnosis and recurrence of eolorectal cancer. Methods:The serum levels of CEA,CA 19-9 and CA72-4 were detected in 72 cases with the group of colorectal cancer ,35 cases with the control group by chemical luminometryo Result:The serum levels of CEA,CA19-9, CA72-4 in the group of coloreetal cancer were significantly higher than those in the controls (average p 〈 0.01 ). Content of three tumor maker were markedly elevated in the group of recun'ence and no recurrence, all these three tumor markers were significantly successful for clinical diagnosis and recurrence of colorectal cancer. In single determination: the positive rate of either CA19-9 or CA72-4 was no different. The sensitivity of combined determination CEA+CA72-4 and CA 19-9 were significantly higher than any single item determination and the other two combination forms,namely CEA+CA19-9, CEA+CA724 及 CA19-9+CA72-4.Conclusion:The sensitivitiy of dignosis of colorectal cancer can be elevated by combined determination CEA,CA19-9,CA72-4 tumor maker, and the diagnostic sensitivity were valuable for detecting recurrence of the colorectal cancer in clinical application.
出处 《中国中医药咨讯》 2011年第3期299-300,共2页
关键词 结直肠癌 肿瘤标志物 复发 colorectal cancer tumor maker recurrence
  • 相关文献

参考文献5

二级参考文献21

  • 1吴健雄 余宏迢 等.CEA和CA242在大肠癌诊断中的意义[J].中华肿瘤杂志,1995,17:438-438.
  • 2李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 3Carpelan-Holnrstrom M, l.ouhimo J, Stenman UH, et al. CEA, CA19-9 and CA72-4 improve the diagnostic accuracy in gastrointestinal cancers.Anticancer Res, 2002, 22: 2311-2316.
  • 4Kim SB, Femandes LC, Saad SS, et al. Assessment of the value of preoperative sermn levels of CA242 and CEA in the staging and postoperative survival of colorectal adenocarcinoma patients. Int J Biol Markers, 2003, 18: 182-187.
  • 5Reiter W, Stieber P, Reuter C, et al. Multivariate analysis of the prognostic value of CEA and CA19-9 serum levels in colorectal cancer.Anticancer Res, 2000, 20.. 5195-5198.
  • 6Grotowski M. Antigens (CEA and CA19-9) in diagnosis and prognosis colorectal cancer. Pol Merkuriusz Lek, 2002, 12: 77-80.
  • 7Bertone P,Snyder M.Advances in functional protein microarray technology.FEBS J,2005,272:5400-5411.
  • 8Giltnane JM,Rimm DL.Technology insight:identification of biomarkers with tissue microarray technology.Nat Clin Pract Oncol,2004,1:104-111.
  • 9Reiter W,Stieber P,Reuter C,et al.Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.Anticancer Res,2000,20:5195-5198.
  • 10Wang WS,Lin JK,Chiou TJ,et al.CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.Hepatogastroenterology,2002,49:160-164.

共引文献94

同被引文献21

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部